Lonza Group Ltd (LZAGY)
58.09
+0.17
(+0.29%)
USD |
OTCM |
May 17, 16:00
Lonza Group Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2017 | -46.92M |
| December 31, 2016 | 29.57M |
| September 30, 2016 | -118.75M |
| June 30, 2016 | -16.57M |
| March 31, 2016 | -47.54M |
| Date | Value |
|---|---|
| December 31, 2015 | -128.50M |
| September 30, 2015 | -73.42M |
| June 30, 2015 | -118.25M |
| March 31, 2015 | -75.75M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Roche Holding AG | -- |
| AC Immune SA | -0.7872M |
| CRISPR Therapeutics AG | 305.93M |
| Addex Therapeutics Ltd | -0.1643M |
| NLS Pharmaceutics Ltd | -- |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow | -325.49M |
| Free Cash Flow Yield | -0.76% |